Historique
Auteur E. SCHATZ
Documents disponibles écrits par cet auteur (13)
Ajouter le résultat à votre sélection Affiner la recherche
V. BELACKOVA ; A. M. SALMON ; E. SCHATZ ; M. JAUNCEY | 2018
Dans Hepatology, Medicine and Policy (Vol.3, n°9, 2018) Article : PériodiqueBackground: Prevalence of Hepatitis C Virus (HCV) among people who inject drugs (PWID) is high. Risky injecting behaviours have been found to decrease in drug consumption rooms (DCRs) and supervised injecting facilities (SIFs), yet HCV preventio[...]
FRANÇAIS : Depuis une dizaine voire une vingtaine d'années, les salles de consommation à moindre risque (SCMR) font partie intégrante des stratégies de traitement de la dépendance aux drogues et de réduction des risques dans plusieurs pays en E[...]
Dans une première partie, le rapport retrace les phases de développement de ce projet financé par la Commission Européenne : de la constitution du réseau européen (comprenant la plupart des pays européens) aux différentes rencontres de travail ([...]
Pour chaque pays européen participant à l'étude des usagers itinérant, le rapport fait un résumé de la situation en matière de drogues, présente les grandes lignes de la politique, décrit le dispositif de soins et le système judiciaire et tente [...]
Research purpose: The aim of this project was to identify and select good practice examples in the field of HCV awareness, testing, access to treatment and care for PWUD in harm reduction and community settings in Europe20 and to offer service [...]
J. M. PERICAS ; D. J. BROMBERG ; D. OCAMPO ; E. SCHATZ ; I. WAWER ; P. WYSOCKI ; K. SAFREED-HARMON ; J. V. LAZARUS | 2019
Dans Harm Reduction Journal (Vol.16, 2019) Article : PériodiqueBackground: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and[...]
L. REID ; D. ELLIS ; S. MERKINAITE ; E. SCHATZ ; K. PRINS-SCHIFFER ; F. X. MAJO ROCA ; A. LEICHT | 2010
BrochureThis booklet was produced within working package 7 under coordination of the Eurasian Harm Reduction Network (EHRN) and provides an overview about Hepatitis C and injecting drug use in Europe, including best practice examples as response to the [...]
P. ROUX ; C. DONADILLE ; C. MAGEN ; E. SCHATZ ; R. STRANZ ; A. CURADO ; T. TSIAKOU ; L. VERDES ; A. ALEKSOVA ; P. CARRIERI ; S. MEZAACHE ; A. BEN CHARIF | 2021
Dans International Journal of Drug Policy (Vol.87, January 2021) Article : PériodiqueBackground: Harm reduction (HR) interventions are essential to reduce human immunodeficiency virus (HIV) and hepatitis C virus (HCV) transmission in people who inject drugs (PWID). Preliminary testing of the Individually Tailored Support and Edu[...]
This article discusses the issues of marginalisation and social inclusion and their particular relevance for the wellbeing of individuals and groups in Europe. Specific attention is paid to the relation between marginalisation and access to heal[...]Nouveauté![Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses [Viewpoint]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=79379)
J. V. LAZARUS ; K. SAFREED-HARMON ; S. R. STUMO ; M. JAUFFRET-ROUSTIDE ; M. MATICIC ; T. REIC ; E. SCHATZ ; J. TALLADA ; M. HARRIS ; HEP-CORE STUDY GROUP | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : PériodiqueIn 2016, the World Health Organization (WHO) called for the elimination of viral hepatitis as a public health threat and established the ambitious targets of achieving an 80% reduction in new infections and a 65% reduction in deaths from hepatit[...]
S. K. WOODS ; Correlation Team, Organisateur de réunion ; E. SCHATZ ; 'Social inclusion and health - Corssing the borders'. Conference report (27-29 September 2007; Sofia) ; K. SCHIFFER | 2007
CongrèsCorrelation, the European network on social inclusion and health organised a three day conference in Sofia, Bulgaria from 27 to 29 September. The conference covered a broad range of topics, targeting marginalised groups and their limited access [...]
M. MATICIC ; Z. PIRNAT ; A. LEICHT ; R. ZIMMERMANN ; T. WINDELINCK ; M. JAUFFRET-ROUSTIDE ; E. DUFFELL ; T. TAMMI ; E. SCHATZ | 2020
Dans Harm Reduction Journal (Vol.17, 2020) Article : PériodiqueBackground: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) t[...]
This paper, written in collaboration with the Correlation Network, briefly describes the history and the basic elements of the Dutch drug dependence treatment policy, including recent trends in drug use and the current drug treatment system impl[...]
